Ally Bridge Group

Venture Capital Active Hong Kong
Last updated 2026-06-18
Portfolio
4
in our dataset
Rounds participated
4
Rounds led
2
Rounds' value
$270.3M
total disclosed, rounds participated
Stages
—

Portfolio · 4

Biobeat
24 Hour Cuff-less Blood Pressure Monitoring
Led ★ 1 round $50.0M committed Latest: 2026-01
Insightec
MR-guided Focused Ultrasound Systems
1 round $150.0M committed Latest: 2024-06
Itamar Medical
Home Sleep Testing and Endothelial Function Assessment
Led ★ 1 round $40.3M committed Latest: 2020-02
Mavrik Dental Systems
Automated Dental Therapies
1 round $30.0M committed Latest: 2020-02

Investment activity

Portfolio by sector

Health Tech & Life Sciences4

Q&A

What is Ally Bridge Group's primary investment focus by sector?
Ally Bridge Group primarily focuses on the Health Tech & Life Sciences sector, with all four of its portfolio companies operating in this area.
Can you name some of Ally Bridge Group's notable portfolio companies?
Ally Bridge Group's portfolio includes Biobeat, which specializes in 24-hour cuff-less blood pressure monitoring, and Insightec, known for its MR-guided Focused Ultrasound Systems.
What is Ally Bridge Group's typical investment range?
Ally Bridge Group typically invests in the range of $30M to $150M.
What is the most recent investment activity by Ally Bridge Group?
Ally Bridge Group made an investment in January 2026, following another in June 2024.
What funding stages does Ally Bridge Group typically participate in?
Ally Bridge Group has participated in various funding stages, including A Round, B Round, G Round, and PIPE rounds.
Has Ally Bridge Group had any portfolio companies acquired?
Yes, Itamar Medical, a company specializing in home sleep testing and endothelial function assessment, was acquired from Ally Bridge Group's portfolio.